1292302-96-5
1292302-96-5
Chemical Structure
DSPE-PEG2000-amine sodium
- CAS No.: 1292302-96-5
- Formula:(C2H4O)nC44H87N2O10P.Na
- Molecular Weight:2000 (Average)
SMILES: O=P(OC[C@H](OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O)(O[Na])OCCNC(OCCOCCN)=O.[n]
Biological Activity: DSPE-PEG2000-amine sodium is a pegylated derivative of 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (HY-112530), which can be used to synthesize solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DSPE-PEG2000-amine sodium | 99.98% | DSPE-PEG2000-amine sodium is a pegylated derivative of 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (HY-112530), which can be used to synthesize solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Gao J, et al. Affibody-based nanoprobes for HER2-expressing cell and tumor imaging. Biomaterials. 2011;32(8):2141-2148. [Content Brief]
- [2]. Farinha D, et al. Combination of Gene Therapy and Chemotherapy in a New Targeted Hybrid Nanosystem to Hepatocellular Carcinoma. Int J Nanomedicine. 2024;19:12505-12527. Published 2024 Nov 22. [Content Brief]
- [3]. Nandi D, et al. Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy. Adv Sci (Weinh). 2023;10(6):e2204900. [Content Brief]
